Shigella flexneri is one of the most prominent pathogenic bacteria in developing countries. In the battle against shigellosis and other bacterial diseases, antibiotic resistance has become an increasing global public health threat. Although the serious phenomenon of multidrug resistance (MDR) has been identified as one of the top three burdens on human health, resistance mechanisms are still poorly understood at the molecular level. In this study, we analyzed genomic data and the evolution of resistance in Shigella flexneri under sequential selection stress from three separate antibiotics: ciprofloxacin (CIP), ceftriaxone (CRO), and tetracycline. Through whole-genome sequencing, 82 chromosomal antibiotic resistance genes were identified. Re-sequencing of the evolved populations identified single nucleotide polymorphisms (SNPs) that contributed to MDR and SNPs that were specific to a single drug. A total of 40 SNPs in 8 genes and 3 intergenic regions, including mutations in metG (L582R) and 1538924, 1538924, and 1538924, appeared under each antibiotic. Several nonsynonymous mutations in gyrB (S464Y), ydgA (E378A), rob (R156H), and narX (K75E) were observed under selective pressure from CIP or CRO. Based on a bioinformatic analysis and previous reports, we discuss the contribution of these mutated genes to resistance. Therefore, more circumspect selection and use of antimicrobial drugs for treating shigellosis is necessary.
Get full access to this article
View all access options for this article.
References
1.
KotloffK.L., WinickoffJ.P., IvanoffB., ClemensJ.D., SwerdlowD.L., SansonettiP.J., AdakG.K., and LevineM.M., 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ., 77:651–666.
2.
LivioS., StrockbineN.A., PanchalingamS., TennantS.M., BarryE.M., MarohnM.E., AntonioM., HossainA., MandomandoI., OchiengJ.B., OundoJ.O., QureshiS., RamamurthyT., TambouraB., AdegbolaR.A., HossainM.J., SahaD., SenS., FaruqueA.S., and AlonsoP.L., 2014. Shigella isolates from the global enteric multicenter study inform vaccine development. Clin. Infect. Dis., 59:933–941.
3.
LintonD.S.2010. “War dysentery” and the limitations of German military hygiene during World War I. Bull. Hist. Med., 84:607–639.
4.
BakerK.S., MatherA.E., McGregorH., CouplandP., LangridgeG.C., DayM., Deheer-GrahamA., ParkhillJ., RussellJ.E., and ThomsonN.R., 2014. The extant World War 1 dysentery bacillus NCTC1: a genomic analysis. Lancet, 384:1691–1697.
5.
SunQ., LanR., WangJ., XiaS., WangY., WangY., JinD., YuB., KnirelY.A., and XuJ., 2013. Identification and characterization of a novel Shigella flexneri serotype Yv in China. PLoS One, 8:e70238.
6.
QiuS., XuX., YangC., WangJ., LiangB., LiP., LiH., YiS., LiuH., CuiX., WuZ., XieJ., JiaL., WangL., HaoR., JinH., WangY., SunY., and SongH., 2015. Shift in serotype distribution of Shigella species in China, 2003–2013. Clin. Microbiol. Infect., 21:252.e5–e8.
7.
LevyS.B., and MarshallB., 2004. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10 (12 Suppl):S122–S129.
8.
TaubesG.2008. The bacteria fight back. Science, 321:356–361.
9.
ZhangW., LuoY., LiJ., LinL., MaY., HuC., JinS., RanL., and CuiS., 2011. Wide dissemination of multidrug-resistant Shigella isolates in China. J. Antimicrob. Chemother., 66:2527–2535.
10.
MartinezJ.L., FajardoA., GarmendiaL., HernandezA., LinaresJ.F., Martínez-SolanoL., and SánchezM.B., 2009. A global view of antibiotic resistance. FEMS Microbiol. Rev., 33:44–65.
11.
LeeH.H., MollaM.N., CantorC.R., and CollinsJ.J., 2010. Bacterial charity work leads to population-wide resistance. Nature, 467:82–85.
12.
DaviesJ., and DaviesD., 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev., 74:417–433.
13.
RuizJ.2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother., 51:1109–1117.
14.
KimJ.Y., KimS.H., JeonS.M., ParkM.S., RhieH.G., and LeeB.K., 2008. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea. Clin. Microbiol. Infect., 14:760–765.
15.
ToprakE., VeresA., MichelJ.B., ChaitR., HartlD.L., and KishonyR., 2012. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nat. Genet., 44:101–105.
16.
PfallerM.A., DiekemaD.J., GibbsD.L., NewellV.A., MeisJ.F., GouldI.M., FuW., ColomboA.L., and Rodriguez-Noriega; Global Antifungal Surveillance Study E., 2007. Results from the Artemis disk global antifungal surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J. Clin. Microbiol., 45:1735–1745.
17.
LiR., LiY., KristiansenK., and WangJ., 2008. SOAP: short oligonucleotide alignment program. BioInformatics, 24:713–714.
18.
LiR., ZhuH., RuanJ., QianW., FangX., ShiZ., LiY., LiS., ShanG., KristiansenK., LiS., YangH., WangJ., and WangJ., 2010. De novo assembly of human genomes with massively parallel short read sequencing. Genome Res., 20:265–272.
19.
KanehisaM., GotoS., HattoriM., Aoki-KinoshitaK.F., ItohM., KawashimaS., KatayamaT., ArakiM., and HirakawaM., 2006. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res., 34:D354–D357.
20.
TatusovR.L., FedorovaN.D., JacksonJ.D., JacobsA.R., KiryutinB., KooninE.V., KrylovD.M., MazumderR., MekhedovS.L., NikolskayaA.N., RaoB.S., SmirnovS., SverdlovA.V., VasudevanS., WolfY.I., YinJ.J., and NataleD.A., 2003. The COG database: an updated version includes eukaryotes. BMC Bioinformatics, 4:41–54.
21.
MagraneM., and ConsortiumUniProt. 2011. UniProt knowledgebase: a hub of integrated protein data. Database (Oxford). bar009.
22.
AshburnerM., BallC.A., BlakeJ.A., ButlerH., DavisA.P., DolinskiK., DwightS.S., and EppigJ.T., 2000. Gene ontology: tool for the unification of biology. Nat. Genet., 25:25–29.
23.
VargasW.A., MartínJ.M., RechG.E., RiveraL.P., BenitoE.P., Díaz-MínguezJ.M., ThonM.R., and SuknoS.A., 2012. Plant defense mechanisms are activated during biotrophic and necrotrophic development of Colletotricum graminicola in maize. Plant Physiol., 158:1342–1358.
24.
CantarelB.L., CoutinhoP.M., RancurelC., BernardT., LombardV., and HenrissatB., 2009. The carbohydrate-active EnZymes database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res., 37:D233–D238.
25.
JehlM.A., ArnoldR., and RatteiT., 2011. Effective—a database of predicted secreted bacterial proteins. Nucleic Acids Res., 39:D591–D595.
26.
ChenL., XiongZ., SunL., YangJ., and JinQ., 2012. VFDB 2012 update: toward the genetic diversity and molecular evolution of bacterial virulence factors. Nucleic Acids Res., 40:D641–D645.
QinJ., LiR., RaesJ., ArumugamM., BurgdorfK.S., ManichanhC., NielsenT., PonsN., LevenezF., YamadaT., MendeD.R., LiJ., XuJ., LiS., LiD., CaoJ., WangB., LiangH., ZhengH., and XieY., 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464:59–65.
29.
KurtzS., PhillippyA., DelcherA.L., SmootM., ShumwayM., AntonescuC., and SalzbergS.L., 2004. Versatile and open software for comparing large genomes. Genome Biol., 5:R12.
30.
NandiT., OngC., SinghA.P., BoddeyJ., AtkinsT., Sarkar-TysonM., Essex-LoprestiA.E., ChuaH.H., PearsonT., KreisbergJ.F., NilssonC., AriyaratneP., RonningC., LosadaL., RuanY., SungW.K., WoodsD., TitballR.W., BeachamI., and PeakI., 2010. A genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence. PLoS Pathog., 6:e1000845.
31.
YangJ., NieH., ChenL., ZhangX., YangF., XuX., ZhuY., YuJ., and JinQ., 2007. Revisiting the molecular evolutionary history of Shigella spp. J. Mol. Evol., 64:71–79.
32.
RossiO., BakerK.S., PhaliponA., WeillF.X., CitiuloF., SansonettiP., GerkeC., and ThomsonN.R., 2015. Draft genomes of Shigella strains used by the STOPENTERICS consortium. Gut Pathog., 7:14.
33.
Alvarez-OrtegaC., OlivaresJ., and MartínezJ.L., 2013. RND multidrug efflux pumps: what are they good for? Front. Microbiol., 4:7.
34.
WangC., YangL., ShahA.A., ChoiE.S., and KimS.W., 2015. Dynamic interplay of multidrug transporters with TolC for isoprenol tolerance in Escherichia coli. Sci. Rep., 5:16505.
35.
WrightD.J., and DrasarB.S., 2014. Dysentery in World War 1: Shigella a century on. Lancet, 384:1651–1653.
ConnorT.R., BarkerC.R., BakerK.S., WeillF.X., TalukderK.A., SmithA.M., BakerS., GoualiM., ThanhD.P., AzmiI.J., and da SilveiraW.D., 2015. Species-wide whole genome sequencing reveals historical global spread and recent local persistence in Shigella flexneri. Elife, 4:e07335.
38.
MatherA.E., BakerK.S., McGregorH., CouplandP., MatherP.L., Deheer-GrahamA., ParkhillJ., BracegirdleP., RussellJ.E., and ThomsonN.R., 2014. Bacillary dysentery from World War 1 and NCTC1, the first bacterial isolate in the national collection. Lancet, 384:1720.
39.
BenvenisteR., and DaviesJ., 1973. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc. Natl Acad. Sci. U.S.A., 70:2276–2280.
40.
MartínezJ.L., and BaqueroF., 2014. Emergence and spread of antibiotic resistance: setting a parameter space. Ups. J. Med. Sci., 119:68–77.
41.
BaqueroF., Alvarez-OrtegaC., and MartinezJ.L., 2009. Ecology and evolution of antibiotic resistance. Environ. Microbiol. Rep., 1:469–476.
42.
RashidH., and RahmanM., 2015. Possible transfer of plasmid mediated third generation cephalosporin resistance between Escherichia coli and Shigella sonnei in the human gut. Infect. Genet. Evol., 30:15–18.
43.
GirgisH.S., HarrisK., and TavazoieS., 2012. Large mutational target size for rapid emergence of bacterial persistence. Proc. Natl Acad. Sci. U.S.A., 109:12740–12745.
44.
TuomanenE., CozensR., ToschW., ZakO., and TomaszA., 1986. The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J. Gen. Microbiol., 132:1297–1304.
45.
PuX.Y., PanJ.C., WangH.Q., ZhangW., HuangZ.C., and GuY.M., 2009. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China. J. Antimicrob. Chemother., 63:917–920.
46.
AzmiI.J., KhajanchiB.K., and AkterF., HasanT.N., ShahnaijM., AkterM., BanikA., SultanaH., HossainM.A., AhmedM.K., FaruqueS.M., and TalukderK.A., 2014. Fluoroquinolone resistance mechanisms of Shigella flexneri isolatedin Bangladesh. PLoS One., 9:e102533.
47.
GuilleminI., JarlierV., and CambauE., 1998. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob. Agents Chemother., 42:2084–2088.
48.
TalukderK.A., KhajanchiB.K., IslamM.A., IslamZ., DuttaD.K., RahmanM., WatanabeH., NairG.B., and SackD.A., 2006. Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1. Curr. Microbiol., 52:108–111.
49.
FàbregaA., MartinR.G., RosnerJ.L., TavioM.M., and VilaJ., 2010. Constitutive SoxS expression in a fluoroquinolone-resistant strain with a truncated SoxR protein and identification of a new member of the marA-soxS-rob regulon, mdtG. Antimicrob. Agents Chemother., 54:1218–1225.
50.
HobbsE.C., YinX., PaulB.J., AstaritaJ.L., and StorzG., 2012. Conserved small protein associates with the multidrug efflux pump AcrB and differentially affects antibiotic resistance. Proc. Natl Acad. Sci. U.S.A., 109:16696–16701.
51.
DuvalV., and ListerI.M., 2013. MarA, SoxS and Rob of Escherichia coli—global regulators of multidrug resistance, virulence and stress response. Int. J. Biotechnol. Wellness Ind., 2:101–124.
52.
ArizaR.R., LiZ., RingstadN., and DempleB., 1995. Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein. J. Bacteriol., 177:1655–1661.
53.
CamaJ., BajajH., PagliaraS., MaierT., BraunY., WinterhalterM., and KeyserU.F., 2015. Quantification of fluoroquinolone uptake through the outer membrane channel OmpF of Escherichia coli. J. Am. Chem. Soc., 137:13836–13843.
54.
RajaS.B., MuraliM.R., and DevarajS.N., 2008. Differential expression of OmpC and ompF in multidrug-resistant Shigella dysenteriae and Shigella flexneri by aqueous extract of Aegle marmelos, altering its susceptibility toward beta-lactam antibiotics. Diagn. Microbiol. Infect. Dis., 61:321–328.
55.
HuynhT.N., NoriegaC.E., and StewartV., 2010. Conserved mechanism for sensor phosphatase control of two-component signaling revealed in the nitrate sensor NarX. Proc. Natl Acad. Sci. U.S.A., 107:21140–21145.
56.
WorthingtonR.J., BlackledgeM.S., and MelanderC., 2013. Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence. Future Med. Chem., 5:1265–1284.
57.
HirakawaH., NishinoK., HirataT., and YamaguchiA., 2003. Comprehensive studies of drug resistance mediated by overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J. Bacteriol., 185:1851–1856.
58.
HirakawaH., NishinoK., YamadaJ., HirataT., and YamaguchiA., 2003. β-Lactam resistance modulated by the overexpression of response regulators of two-component signal transduction systems in Escherichia coli. J. Antimicrob. Chemother., 52:576–582.
59.
BannJ.G., and FriedenC., 2004. Folding and domain-domain interactions of the chaperone PapD measured by 19F NMR. Biochemistry, 43:13775–13786.
60.
JusticeS.S., HunstadD.A., HarperJ.R., DuguayA.R., PinknerJ.S., BannJ., FriedenC., SilhavyT.J., and HultgrenS.J., 2005. Periplasmic peptidyl prolyl cis-trans isomerases are not essential for viability, but SurA is required for pilus biogenesis in Escherichia coli. J. Bacteriol., 187:7680–7686.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
